RxDoctor Payments DataLook up a doctor →

Sanjeev Jain, PhD

Allergy & Immunology · Longview, WANPI 1710973839

Payments from drug & device makers

$391,577in general payments, 2019–2025

Across 1,283 payments — averaging $305.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$230K
  • Pfizer$89K
  • Aimmune Therapeutics, Inc.$33K
  • Biocryst Pharmaceuticals, Inc.$14K
  • AstraZeneca$5K
  • GSK$4K
  • plus $17K from 42 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis57$229,846
Pfizer86$88,906
Aimmune Therapeutics, Inc.11$32,613
Biocryst Pharmaceuticals, Inc.5$14,214
AstraZeneca183$4,578
GSK263$4,479
Takeda Pharmaceuticals U.S.A., Inc.68$4,227
CSL Behring85$1,621
Grifols USA, LLC142$1,474
Octapharma USA, Inc.19$1,028
Sanofi42$1,013
Amgen(2 entities)37$1,010
Regeneron Healthcare Solutions, Inc.33$864
Genentech USA, Inc.43$767
Blueprint Medicines Corporation19$546
Boehringer Ingelheim25$527
Biocryst US Sales Co., LLC17$404
Kaleo, Inc.16$367
AbbVie14$318
Pharming Healthcare, Inc.14$301
Optinose US, Inc.13$280
Teva Pharmaceuticals USA, Inc.13$264
Harmony Biosciences LLC4$200
ADMA Biomanufacturing LLC8$180
Tersera Therapeutics LLC7$167
Bio Products Laboratory USA, Inc.8$160
Shire North American Group Inc8$147
ARS Pharmaceuticals Operations, Inc.5$126
Sanofi-aventis U.S. LLC2$99
Merck4$94
Astrazeneca UK Limited1$87
Covis Pharma GmbH3$78
Alk-abello, Inc4$77
Greer Laboratories, Inc.2$58
Mylan Specialty L.p.2$53
Lilly USA, LLC2$46
Kowa Pharmaceuticals America, Inc.2$45
Phadia US Inc.2$45
Galderma Laboratories, L.p.2$37
Cycle Pharmaceuticals Inc2$34
Dermavant Sciences, Inc.1$27
Viatris Specialty LLC1$26
Incyte Corporation1$26
Organon2$26
Circassia Inc.2$26
Xeris Pharmaceuticals, Inc.1$23
Verona Pharma, Inc.1$22
Genentech, Inc.1$21

How this compares

$391,577 in reported general payments places this provider in the 95th percentile of 81 allergy & immunology providers in Washington.

See all allergy & immunology providers in Washington →

Medicare billing

Part B allowed, 2024
$249,275
Medicare patients
312
Services billed
12,620

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other allergy & immunology in Longview

See the full list for Washington →

Where these figures come from

Is this you, or does something look wrong? →